Alternative lengthening of telomeres in mammalian cells
- PMID: 11850785
- DOI: 10.1038/sj.onc.1205058
Alternative lengthening of telomeres in mammalian cells
Abstract
Some immortalized mammalian cell lines and tumors maintain or increase the overall length of their telomeres in the absence of telomerase activity by one or more mechanisms referred to as alternative lengthening of telomeres (ALT). Characteristics of human ALT cells include great heterogeneity of telomere size (ranging from undetectable to abnormally long) within individual cells, and ALT-associated PML bodies (APBs) that contain extrachromosomal telomeric DNA, telomere-specific binding proteins, and proteins involved in DNA recombination and replication. Activation of ALT during immortalization involves recessive mutations in genes that are as yet unidentified. Repressors of ALT activity are present in normal cells and some telomerase-positive cells. Telomere length dynamics in ALT cells suggest a recombinational mechanism. Inter-telomeric copying occurs, consistent with a mechanism in which single-stranded DNA at one telomere terminus invades another telomere and uses it as a copy template resulting in net increase in telomeric sequence. It is possible that t-loops, linear and/or circular extrachromosomal telomeric DNA, and the proteins found in APBs, may be involved in the mechanism. ALT and telomerase activity can co-exist within cultured cells, and within tumors. The existence of ALT adds some complexity to proposed uses of telomere-related parameters in cancer diagnosis and prognosis, and poses challenges for the design of anticancer therapeutics designed to inhibit telomere maintenance.
Similar articles
-
Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.Cancer Res. 2005 Apr 1;65(7):2722-9. doi: 10.1158/0008-5472.CAN-04-2881. Cancer Res. 2005. PMID: 15805271
-
DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.Cancer Res. 2007 Aug 1;67(15):7072-7. doi: 10.1158/0008-5472.CAN-07-1556. Epub 2007 Jul 24. Cancer Res. 2007. PMID: 17652140
-
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.Oncogene. 1999 Jun 3;18(22):3383-90. doi: 10.1038/sj.onc.1202752. Oncogene. 1999. PMID: 10362359
-
Telomere length maintenance--an ALTernative mechanism.Cytogenet Genome Res. 2008;122(3-4):281-91. doi: 10.1159/000167814. Epub 2009 Jan 30. Cytogenet Genome Res. 2008. PMID: 19188697 Review.
-
Immortalized cells with no detectable telomerase activity. A review.Biochemistry (Mosc). 1997 Nov;62(11):1254-62. Biochemistry (Mosc). 1997. PMID: 9467849 Review.
Cited by
-
Stable expression of promyelocytic leukaemia (PML) protein in telomerase positive MCF7 cells results in alternative lengthening of telomeres phenotype.Genome Integr. 2012 Aug 27;3(1):5. doi: 10.1186/2041-9414-3-5. Genome Integr. 2012. PMID: 22925423 Free PMC article.
-
Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct.J Nucl Med. 2006 Feb;47(2):270-7. J Nucl Med. 2006. PMID: 16455633 Free PMC article.
-
Structure of Dictyostelium discoideum telomeres. Analysis of possible replication mechanisms.PLoS One. 2019 Sep 24;14(9):e0222909. doi: 10.1371/journal.pone.0222909. eCollection 2019. PLoS One. 2019. PMID: 31550289 Free PMC article.
-
Aging and immortality in a cell proliferation model.J Theor Biol. 2007 Oct 7;248(3):411-7. doi: 10.1016/j.jtbi.2007.06.009. Epub 2007 Jun 12. J Theor Biol. 2007. PMID: 17631317 Free PMC article.
-
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12606-11. doi: 10.1073/pnas.182407599. Epub 2002 Aug 22. Proc Natl Acad Sci U S A. 2002. PMID: 12193655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources